Advertisement

Cranial irradiation and cerebrospinal fluid levels of 6-mercaptopurine in children with acute leukemia

  • Riccardo Riccardi
  • Anna Lasorella
  • Rosa Laura Tartaglia
  • Anna Riccardi
  • Tiziana Servidei
  • Renato Mastrangelo
Article

Abstract

We measured 6-mercaptopurine levels in the cerebrospinal fluid and plasma of 15 children undergoing treatment for acute leukemia. Plasma and cerebrospinal fluid samples obtained by lumbar puncture were collected before, during, and after cranial irradiation in order to evaluate a possible change in blood-brain barrier permeability to orally administered 6-mercaptopurine. Considerable interpatient variability has been observed in both plasma and cerebrospinal fluid 6-mercaptopurine levels. No statistical differences in the 6-mercaptopurine cerebrospinal fluid levels under the three different conditions could be detected. Our data suggest that cranial irradiation does not significantly influence the cerebrospinal fluid levels.

Key words

6-Mercaptopurine Cranial irradiation Childhood leukemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Riehm H, Gadner H, Henze G, Kornhuber B, Langermann H J, Muller-Weihrich S, Schellong G: Acute lymphoblastic leukemia: treatment results in three BFM studies (1970–1981), in Murphy S B, Gilbert J L (eds):Leukemia Research: Advances in Cell Biology and Treatment, pp. 251–263. Elsevier (1983).Google Scholar
  2. 2.
    Aur R J A, Simone J, Hustu H O, Walters T, Borella L, Pratt C, Pinkel D: Central nervous system therapy and combination chemotherapy of childhood ALL.Blood 37, 272 (1971).PubMedGoogle Scholar
  3. 3.
    Price R A, Jamieson P A: The central nervous system in childhood leukemia II. Subacute encephalopathy.Cancer 35 (2), 306 (1975).PubMedCrossRefGoogle Scholar
  4. 4.
    Creutzig U, Ritter J, Riehm H, Langermann H J, Henze G, Kabish H, Niethammer D, Jurgens H, Stollman B, Lasson U, Kaufman U, Loffler H, Schellong G: Improved treatment results in childhood acute myelogeneous leukemia: a report from the German cooperative study AML BFM 78.Blood 65, 298 (1985).PubMedGoogle Scholar
  5. 5.
    Narang P R, Jeager R L, Chatterji D C: Quantification of 6-MP in biologic fluid using HPLC: a selective and novel procedure.J Chromat 230, 373 (1982).CrossRefGoogle Scholar
  6. 6.
    Tidd D M, Peterson A P R: A biochemical mechanism for the delayed cytotoxic reaction of 6- mercaptopurine.Cancer Res 34, 738 (1974).PubMedGoogle Scholar
  7. 7.
    Griffin T W, Rasey J S, Bleyer W A: The effect of photon irradiation on blood brain barrier permeability to MTX in mice.Cancer 40 (3), 1109 (1977).PubMedCrossRefGoogle Scholar
  8. 8.
    Clemente C D, Holst E A: Pathological changes in neurons neuroglia and blood brain barrier induced by X irradiation of the head of monkeys.AMA Arch Neurol Psychiat 71, 66 (1954).Google Scholar
  9. 9.
    Hayder S, Lafolie P, Bjork O, Ahstrom L, Perteson C: 6-Mercaptopurine in cerebrospinal fluid during oral maintenance therapy of children with acute lymphoblastic leukemia.Med Oncol tumor Pharma-cother 5 (3), 187 (1988).Google Scholar
  10. 10.
    Riccardi R, Balis F, Ferrara P, Poplack D G, Mastrangelo R: Influence of food intake on bioavail-ability of oral 6-MP in children with acute lymphoblastic leukemia.Pediat Hematol Oncol 3 (4), 319 (1986).CrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1991

Authors and Affiliations

  • Riccardo Riccardi
    • 1
  • Anna Lasorella
    • 1
  • Rosa Laura Tartaglia
    • 1
  • Anna Riccardi
    • 1
  • Tiziana Servidei
    • 1
  • Renato Mastrangelo
    • 1
  1. 1.Division of Pediatric OncologyCatholic University of RomeRomeItaly

Personalised recommendations